| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0008 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |